The pimple is gone. The mark is still there. Three months later, six months later, sometimes a year later. The cluster of brown or purplish spots on your cheekbones, your jaw, your forehead - they came from skin that has already healed. So why are they still visible? And what actually makes them fade?
This is one of the most searched questions in skincare, and it's also one of the most poorly answered. Most of what you're treating isn't a scar in the way you think it is. Once you know what it actually is, the answer about what works gets a lot clearer.
When people say "acne scars," they usually mean one of two completely different things.
The dark marks - brown, purple, or grayish patches where a pimple used to be. These are flat. You can't feel them with your finger. This is post-inflammatory hyperpigmentation, or PIH, and it is not technically a scar. It's the skin doing exactly what it's supposed to do - producing melanin to protect itself from inflammation - just for too long, after the inflammation is over.
The indents - the small pits, depressions, and uneven texture you can actually feel. These are atrophic scars - icepick, rolling, or boxcar in shape. They're the result of collagen architecture that was damaged during deeper acne and didn't fully rebuild.
These are different problems with different solutions. Topical skincare can do real, meaningful work on the first. It can't fully solve the second, no matter what the marketing promises.
When skin is inflamed - from acne, but also from picking, harsh products, or even sun exposure on healing skin - melanocytes (the cells that produce pigment) get a signal to ramp up. Melanin is your skin's natural defense against skin barrier damage. It's protective by design.
The problem is that for many people, especially those with more melanin in their skin to begin with, the melanocytes don't quiet down when the inflammation is over. They keep producing. The result is a flat dark mark that can persist for months, even years, without intervention.
So treating PIH isn't really about "fading" anything topically in a passive sense. It's about interrupting the melanin-production process at multiple points, while also calming the underlying inflammation that keeps triggering it.
Effective topical treatment for PIH works on four mechanisms at once. No single ingredient does all four, which is why thoughtfully formulated products combine several.
Cell turnover moves pigmented cells up and off the surface faster. Gentle acid exfoliants like mandelic acid and lactic acid do this - and importantly, they're better tolerated on melanin-rich skin than aggressive exfoliants like glycolic acid, which can trigger more PIH.
Tyrosinase pathway interference stops melanin from being made in the first place. Tyrosinase is the enzyme that produces melanin. Several well-studied ingredients block it at different points: niacinamide, azelaic acid (and its gentler derivative potassium azeloyl diglycinate), licorice root (glabridin), bearberry (a natural source of arbutin), and oxyresveratrol from monkey fruit. Stacking these is more effective than relying on one.
Inflammation reduction breaks the cycle by calming what's triggering melanin overproduction. Niacinamide, gotu kola, oat extract, and antioxidants all do this through different routes.
Barrier repair helps the skin recover faster overall. Stronger barriers produce less inflammation. Ingredients like squalane, ceramide-supportive lipids, and rice ferment matter here.
Motif's Renew Resurfacing Peptide Toner is built around the first two - gentle acid turnover plus a brightening peptide that has outperformed kojic acid and arbutin in head-to-head testing. Motif's Power Brightening Bicelle Serum is built around the next three - five different tyrosinase-pathway ingredients, layered antioxidants, and a barrier-rich base. Used together, they hit the PIH problem from multiple directions at once.
Hydroquinone is the most studied prescription treatment for PIH and is genuinely effective in the short term. It also carries real risks - particularly for darker skin tones, where long-term or higher-concentration use has been linked to a condition called exogenous ochronosis, which causes blue-black discoloration that's worse than the original PIH. It's been restricted or banned over-the-counter in much of Europe, Asia, and several other regions for these reasons.
Gentler, multi-pathway formulations that combine niacinamide, azelaic-acid derivatives, and botanical tyrosinase inhibitors deliver real results without the same risk profile. They take longer. They're better tolerated. And critically, they work for the people who need them most.
This is the most important paragraph in the post.
PIH does not fade in two weeks. The honest, evidence-based timeline is three to six months of consistent treatment for visible improvement, and up to a year for deeper or older marks. The skincare aisle is full of products promising fast results. The skin is not interested in your timeline.
The good news: once PIH starts responding, it tends to continue improving. The work compounds. The discipline is just showing up daily, for months, while telling yourself it's working.
Atrophic scars - the actual indents - require something topicals cannot offer: physical remodeling of the skin's collagen architecture. The procedures that work on this are microneedling, fractional laser resurfacing, subcision (a technique that releases tethered scar tissue from underneath), and dermal fillers.
These work, but they come with caveats - especially for melanin-rich skin. The same inflammation that triggered the original PIH can be triggered by procedures themselves, meaning that microneedling, lasers, and chemical peels can sometimes cause more PIH than they solve if not done by a practitioner experienced with darker skin tones. Specific lasers (Q-switched Nd:YAG, picosecond) and lower-aggression microneedling are safer choices for melanin-rich skin. If you're considering procedures, the question to ask isn't "What device do you use?", It's - "How many patients with my skin tone have you treated, and what's your PIH rate?"
Most of the marks you're trying to get rid of will fade with the right topical formulation and the patience to give it three to six months. The marks you can actually feel - the indents - need a different kind of intervention, and require careful provider selection if your skin is melanin-rich.
The right tools, used consistently, beat the wrong procedure dramatically. Know what you're treating. Match the intervention to the problem.
How to get rid of acne scars fast?
The honest answer is that you can't, not for the marks most people are trying to get rid of. PIH responds to consistent treatment over three to six months. Anything claiming faster results is either marketing language, an aggressive ingredient that may cause more inflammation, or a procedure with real risks. The faster path is starting consistent multi-pathway treatment now, not chasing a shortcut.
How to get rid of acne scars and dark spots at home?
The "dark spots" most people are referring to are PIH, which responds well to home treatment with the right ingredients - gentle acids for cell turnover (mandelic, lactic), tyrosinase pathway ingredients (niacinamide, azelaic acid, licorice, arbutin), and antioxidants. Consistent use, daily SPF, and patience produce real results without procedures.
Will SPF actually help my acne scars fade?
Yes - significantly. UV exposure triggers more melanin production, which compounds existing PIH. Daily broad-spectrum SPF is non-negotiable if you're treating dark marks. Without it, you're working against yourself.
Should I exfoliate to get rid of acne scars?
Gentle exfoliation helps; aggressive exfoliation often makes things worse. Mandelic and lactic acids and gluconolactone are safer choices for melanin-rich skin than glycolic acid. Physical scrubs and harsh peels can trigger more inflammation, which triggers more PIH - the opposite of what you want.
Written by Devanshi Garg, Founder of Motif Skincare. The Motif editorial process is informed by ongoing collaboration with our Chief Dermatology Advisor, Dr. Indy Chabra, MD, board-certified dermatologist with a Ph.D. in Microbiology and Genetics. This article is for educational purposes only and does not constitute medical advice.
